The Benefits of a Guideline on Safe Termination of Pregnancy for Legal Indications: An Illustrative Case Report of a Hydranencephaly

Zubaida G. Abdullahi, Oladapo S. Shittu, Afolabi K. Koledade, Usman Mohammed, Hafsat A. Maikudi, Joseph B. Igashi, Nafisa Bello

Abstract

After years of the worsening burden of unsafe abortion and attendant morbidities and mortalities in Nigeria, a National Guideline on the Safe termination of pregnancy for legal indications was enunciated. This report presents and discusses an illustrative case of a hydranencephaly that benefited from it. A 43-year old multipara was informed during routine ultrasonography at booking for
antenatal care, at 16 weeks of gestation, of a major defect in her baby and advised to meet her physician. Following a repeat highresolution ultrasonography and discussions between the Obstetricians, Neurosurgeon, and Ultrasonologist, the woman was counseled on the diagnosis. At her insistence and provision of written consent, medical abortion with Mifepristone and Misoprostol was successfully instituted. (Afr J Reprod Health 2019; 23[2]: 148-151)

Full Text:

PDF

References

Federal Ministry of Health. February 2018. National

Guidelines on Safe Termination of Pregnancy for Legal Indications.

Pant S, Kaur G and JK De. Hydranencephaly. Kathmandu

University Medical Journal 2010;8(1 issue 29):83-

Sepulveda W, Cortes-Yepes H, Wong AE, Dezerega V,

Corral E, and Malinger G. Prenatal sonography in

hydranencephaly: findings during the early stages

of the disease. J Ultrasound Med 2012;31(5):799-

Kishore C, Parveen C and Pramod SJ. Scaling new heights

to diagnose hydranencephaly. IOSR-JDMS 2016;15(9):4-10.

Bayers BD, Barth WH, Stewart TL and Pierce BT.

Ultrasound and MRI appearance of hydranencephaly in utero: a case report. J Reprod Med 2005; 50(1):53-56.

Quek YW, Su PH, Tsao TF, Chen JY, Ng YY, Hu JM and

Chen SJ. Hydranencephaly Associated with Interruption of Bilateral Internal Carotid Arteries. Pediatr Neonatol 2008;49(2):43−47.

Oladapo OT, Adetoro OO, Ekele BA, Chama C, Etuk SJ,

Aboyeji AP, Onah HE, Abasiattai AM, Adamu AN,

Adegbola O, Adeniran AS, Aimakhu CO, Akinsanya O, Aliyu LD, Ande AB, Ashimi A, Bwala M, Faamwo A, Geidam AD, Ikechebelu JI, Imaralu JO, Kuti O, Nwachukwu D, Omo-Aghoja L, Tunau K, Tukur J, Umeora O, Umezulike AC, Dada OA, Tuncalp O, Vogel JP and Gulmezoglu AM; Nigeria Near-miss and Maternal Death Surveillance Network. When getting

there is not enough: a nationwide cross-sectional

study of 998 maternal deaths and 1451 near-misses in

public tertiary hospitals in a low-income country.

BJOG 2016; 123 (6): 928-38. DOI: 10.1111/1471-

13450.

Okonofua F, Shittu O, Shochet T, Diop A and Winikoff B.

Acceptability and feasibility of medical abortion

with mifepristone and misoprostol in Nigeria. Int J

Gynecol Obstet 2014; 125:47-52.

Ford N, Mofenson L, Shubber Z, Calmy A, AndrieuxMayer I, Vitoria M, Shaffer N and Renaud Fl. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and metaanalysis. AIDS 2014; 28 suppl 2: 123-31.

Refbacks

  • There are currently no refbacks.